When will Selumetinib be available in China?

Selumetinib is used to treat neurofibromatosis (a genetic disorder that causes tumors to develop on the nerves) in children at least 2 years old and also in children with unresectable plexiform neurofibromas. Neurofibromatosis can cause brain or spinal cord tumors, learning disabilities, tumors on or under the skin, or bone deformities. Plexiform neurofibromas are large tumors that grow from nerves anywhere in the body and can become cancerous later in life.

The most common side effects of selumetinib are vomiting, rash, increased blood creatine phosphokinase (an enzyme released into the blood when muscles are damaged), diarrhea, nausea, weakness, dry skin, fever, acne-like rash, hypoalbuminemia (low levels of albumin, a blood protein), increased aspartate aminotransferase (an enzyme that indicates a possible sign of liver problems), and paronychia.

SelumetinibThe original drug has been launched in China, but it has not yet entered the scope of medical insurance. SpecificationsThe price of 10mg*60 pills per box may be more than 20,000 yuan, which is relatively expensive. This drug may be sold in local hospitals or pharmacies in China. The original drug selumetinib is provided in capsule form and is currently only available through a doctor's prescription. The patient's treatment should be under the guidance and supervision of a doctor experienced in the diagnosis and treatment of Neurofibromatosistype 1 related tumors. The drug should not be used at will.

The price of selumetinib original drug sold overseas, specifications10mg*60 capsules per box, may be more than 50,000 yuan (the price may fluctuate due to the exchange rate). The ingredients of selumetinib original drug sold domestically and abroad are basically the same. There is currently no generic version of selumetinib on the market. For more drug information and specific prices, please consult the medical consultant of the drug.